These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23245256)

  • 1. Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays.
    Kubiak RJ; Zhang L; Zhang J; Zhu Y; Lee N; Weichold FF; Yang H; Abraham V; Akufongwe PF; Hewitt L; Robinson S; Liu W; Liu X; Patnaik MM; Spitz S; Wu Y; Roskos LK
    J Pharm Biomed Anal; 2013 Feb; 74():235-45. PubMed ID: 23245256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regarding confirmatory immunogenicity assays.
    Coleman D; Hendricks R; Delarosa R; Wakshull E
    J Pharm Biomed Anal; 2013 Oct; 84():173-6. PubMed ID: 23838084
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical immunogenicity specificity assessments: a platform evaluation.
    Peng K; Siradze K; Quarmby V; Fischer SK
    J Pharm Biomed Anal; 2011 Feb; 54(3):629-35. PubMed ID: 21035975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical considerations for calculation of immunogenicity screening assay cut points.
    Hoffman D; Berger M
    J Immunol Methods; 2011 Oct; 373(1-2):200-8. PubMed ID: 21906599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distribution.
    Schlain B; Amaravadi L; Donley J; Wickramasekera A; Bennett D; Subramanyam M
    J Immunol Methods; 2010 Jan; 352(1-2):161-8. PubMed ID: 19891969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.
    Mikulskis A; Yeung D; Subramanyam M; Amaravadi L
    J Immunol Methods; 2011 Feb; 365(1-2):38-49. PubMed ID: 21130095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel data analysis methods to overcome cut point challenges and enable comprehensive assessment of antidrug binding activity in confirmatory assays.
    Mikulskis A; Yeung D; Chen W; Mehta D; Amaravadi L
    J Immunol Methods; 2013 Jun; 392(1-2):38-48. PubMed ID: 23541489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity testing strategy and bioanalytical assays for antibody-drug conjugates.
    Hoofring SA; Lopez R; Hock MB; Kaliyaperumal A; Patel SK; Swanson SJ; Chirmule N; Starcevic M
    Bioanalysis; 2013 May; 5(9):1041-55. PubMed ID: 23641695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity issues in drug development.
    Swanson SJ
    J Immunotoxicol; 2006 Sep; 3(3):165-72. PubMed ID: 18958697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics.
    Finco D; Baltrukonis D; Clements-Egan A; Delaria K; Gunn GR; Lowe J; Maia M; Wong T
    J Pharm Biomed Anal; 2011 Jan; 54(2):351-8. PubMed ID: 20863644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine.
    Carrasco-Triguero M; Yi JH; Dere R; Qiu ZJ; Lei C; Li Y; Mahood C; Wang B; Leipold D; Poon KA; Kaur S
    Bioanalysis; 2013 May; 5(9):1007-23. PubMed ID: 23641693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics.
    Gorovits B; Wakshull E; Pillutla R; Xu Y; Manning MS; Goyal J
    J Immunol Methods; 2014 Jun; 408():1-12. PubMed ID: 24861938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the development and validation of confirmatory anti-drug antibody assays.
    Jani D; Marsden R; Mikulskis A; Gleason C; Klem T; Krinos Fiorotti C; Myler H; Yang L; Fiscella M
    Bioanalysis; 2015; 7(13):1619-31. PubMed ID: 26226311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of analytical detection concepts to immunogenicity testing.
    Klakamp SL; Lu H; Tabrizi M; Funelas C; Roskos LK; Coleman D
    Anal Chem; 2007 Nov; 79(21):8176-84. PubMed ID: 17922557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmatory cut point has limited ability to make accurate classifications in immunogenicity assays.
    Kubiak RJ; Arends RH; Lee N; Liang M; Zhang J; Roskos LK
    Bioanalysis; 2020 Feb; 12(4):245-256. PubMed ID: 32090586
    [No Abstract]   [Full Text] [Related]  

  • 16. A false sense of security? Can tiered approach be trusted to accurately classify immunogenicity samples?
    Jaki T; Allacher P; Horling F
    J Pharm Biomed Anal; 2016 Sep; 128():166-173. PubMed ID: 27262992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirming human antibody responses to a therapeutic monoclonal antibody using a statistical approach.
    Neyer L; Hiller J; Gish K; Keller S; Caras I
    J Immunol Methods; 2006 Aug; 315(1-2):80-7. PubMed ID: 16935294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical evaluation of several methods for cut-point determination of immunogenicity screening assay.
    Shen M; Dong X; Tsong Y
    J Biopharm Stat; 2015; 25(2):269-79. PubMed ID: 25356783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical and bioanalytical considerations for establishing a depletion criterion for specificity testing during immunogenicity assessment of a biotherapeutic.
    Driscoll RO; Zhou L; Moxness M; Mytych D; Chirmule N; Jawa V
    AAPS J; 2013 Oct; 15(4):1160-7. PubMed ID: 23990502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
    Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.